期刊文献+

哈萨克族心力衰竭患者血浆和肽素浓度变化及临床意义 被引量:3

Changes and clinical significance of Copeptin levels in Kazaks patients with heart failure
下载PDF
导出
摘要 目的探讨哈萨克族心力衰竭(HF)患者血浆和肽素(Copeptin)水平变化以及在临床中的意义。方法选取2009年12月~2010年4月收治的哈族HF患者90例(NYHAⅡ~Ⅳ级),选取同期住院无心功能不全患者30例(NYHAⅠ级),采空腹静脉血,测定血浆Copeptin、总胆固醇(TC)、三酰甘油(TG)、血糖(FPG)、高密度脂蛋白(HDL-C)、低密度脂蛋白(LDL-C)、载脂蛋白A1(Apo-A1)和载脂蛋白B(Apo-B),计算体质指数(BMI),超声心动图测量左房内径(LAD)、左室舒张末内径(LVEDD)、左室射血分数(LVEF)、左室短轴缩短率(FS)等指标。结果哈族HF患者血浆Copeptin显著高于对照组,并随NYHA心功能分级的升高而升高,各组间差异均有统计学意义(P<0.01)。相关分析显示,血浆Copeption与心功能分级、LAD、LVEDD呈正相关(P<0.01),与LVEF、FS呈负相关(P<0.01)。结论哈族HF患者血浆Copeptin水平显著升高并与HF病情程度有良好的相关性,与左心扩大程度呈正相关。Copeptin可以作为判断哈族HF患者心功能的一个良好指标。 [Objective] To explore the changes and significance of Copeptin in Kazaks patients with heart failure (HF). [Methods] The 90 Kazaks patients with heart failure (HF) were analyzed as HF group, and 30 patients without heart failure were served as Control group. Every subject's plasma Copeptin was detected by ELISA. The parameters of left atrial diameter (LAD), left ventricle end-diastolic diameter (LVEDD), left ventricle ejection fraction (LVEF), fraction shortening (FS) were detected with echocardiography. [Results] The plasma Copeptin levels of HF group were significantly higher than control group (P〈0.01). Copeptin levels also increased with the classification of NYHA (P 〈0.01). The levels of Copeptin positively correlated with LAD, LVEDD (P〈0.01), and was negatively correlated with LVEF, FS (P〈0.01). [Conduslon] The concentration of Copeptin is increased in Kazaks Patients with heart failure, which is closely associated with NYHAgrading of cardiac function. Measuring plasma Copeptin level may be helpful for judging the severity of HF.
出处 《中国现代医学杂志》 CAS CSCD 北大核心 2011年第17期2000-2003,共4页 China Journal of Modern Medicine
关键词 心力衰竭 和肽素 哈萨克族 heart failure Copeptin Kazaks
  • 相关文献

参考文献14

  • 1HUNT SA, ABRAHAM WT, CHIN MH, et al. ACC/AHA 2005Guideline Update for the Diagnosis and Management of ChronicHeart Failure in the Adult: a Report of the American College ofCardiology/American Heart Association Task Force on PracticeGuidelines (Writing Committee to Update the 2001 Guidelinesfor the Evaluation and Management of Heart Failure): developedin collaboration with the American College of Chest Physiciansand the international Society for Heart and Lung Transplantation:endorsed by the Heart Rhythm Society[J]. Circulation, 2005, 112(12): 154-235.
  • 2GEGENHUBER A, STRUCK J, BERGMANN A, et M. Compara-tire evaluation of B-type natriurefic peptide, mld-regionalpro-A-type natriuretic peptide,mid-dregional pro-adrenmedullin,and Copeptin to predict 1-year mortality in patients with acutedestabilized heart failure[J]. Card Fail, 2007, 13(1): 42-49.
  • 3杨毅宁,马依彤,刘芬,黄定,李晓梅,黄莺,唐琪,陈邦党,马翔,谢翔,杜雷,高霞,王迎洪,古丽娜尔·白托拉,于子翔.新疆汉、维吾尔、哈萨克族慢性心力衰竭流行病学调查及其患病率研究[J].中华心血管病杂志,2010,38(5):460-464. 被引量:48
  • 4陆再英,钟南山,谢毅,等内科学[M].第7版.北京:人民卫生出版社.2006:165-181.
  • 5NAKAMURA T, FUNAYAMA H, YOSHIMURA A, et al. Possi-ble vascular role of increased plasma arginine vssopressin incongestive heart failure [J]. International Journal of Cardiology,2006, 106(2):191-195.
  • 6ROSSI GP. Arginine vasopressin receptor antagonists for heart failure[J]. J Am Coll Cardiol, 2007, 49(22): 2160-2162.
  • 7MORGENTHALER NG, STRUCK J, BERGAMANN A, et al.Assay for the measurement of copeptin, a stable peptide derivedfrom the precursor of vasopressin [J]. Clin Chen, 2006, 52(1):112-119.
  • 8STOISER B, MORTL D, MORGENTHALER NG, et al. Copeptin,a fragment of the vasopressin precursor, as a novel predictor ofoutcome in heart failure [J]. Eur J Clin Invest, 2006, 36(11):771-778.
  • 9KHAN SQ, DHILLON OS, QUINN PA, et al. C-terminal prova-sopressin (copeptin) as a novel and prognostic marker in acutemyocardial in farction:Leicester Acute Myocardial Infarction Pep-tide (LAMP) study[J]. Circulation, 2007, 115(16): 2103-2110.
  • 10STOLZ D, CHRIST-CRAIN M, MIEDINGER D, et al.Copeptin, C-reactive protein,and procaleitonin as prognosticbiomarkers in acute exacerbation of COPD[J]. Chest, 2007, 131(4): 1058-1067.

二级参考文献29

  • 1徐新娟,汪师贞.新疆地区高血压流行病学调查研究回顾[J].新疆医科大学学报,2004,27(3):312-314. 被引量:56
  • 2李春盛,田茹敏,高秀兰,李爱民,齐平.急性心肌梗塞患者血浆内阿片肽和精氨酸加压素含量及其临床意义[J].中国危重病急救医学,1996,8(5):287-289. 被引量:9
  • 3陆再英.心力衰竭.见:叶任高.主编.内科学.第6版.北京:人民卫生出版社,2006.161-166.
  • 4Kannel WB,Ho K,Thorn T.Changing epidemiological features of cardiac failure.Br Heart J,1994,72:S3-S9.
  • 5Kawamura H,Jumabay M,Mitsubayashi H,et al.24-hour,blood pressure in Uygur,Kazakh and Han elderly subjects in China.Hypertens Res,2000,23:177-185.
  • 6American Heart Association.2002 Heart and Stroke Statistical Up data.Dallas,TX:American Heart Association,2002:19.
  • 7Cleland JG,Daubert JC,Erdmann E,et al.The effect of cardiac resynchronization on morbidity and mortality in heart failure.N Engl.J Med,2005,352:1539-1549.
  • 8Hupf H, Grimm D, Schunkert H, et al. Evidence for a vasopressin system in the rat heart. Circ Res. 1999,29:35.
  • 9Valli G, Fedeli A, Palange P, et al. Water and sodium imbalance in COPD patients. Monaldi Arch Chest Dis. 2004,61 (2) :112.
  • 10Friedmann AS. , Mallot KA. , North WG. , et al. Products of vasopressin gene expression in small - cell carcinoma of the lung. Br J Cancer. 1994,69:260.

共引文献64

同被引文献17

引证文献3

二级引证文献15

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部